Pure Global AI
ANVISA registration 81086830040Active

CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)

ANVISA Registration Number: 81086830040FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDARECIPE CHEMICALS INSTRUMENTS GMBHRisk Class II
Device names
Technical name
CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)
PT: CATECOLAMINA (NORADRENALINA, ADRENALINA, DOPAMINA E DERIVADOS)
Commercial name
ClinRep® HPLC Complete Kit Catecholamines in Plasma
Risk class
Class II
Registration details
Registration Number
81086830040
Process Number
25351564705202134
CNPJ
20037992000139
Company information
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Aug 12, 2021
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830040 and manufactured by RECIPE CHEMICALS INSTRUMENTS GMBH. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.